30 results on '"Bartos, Csilla"'
Search Results
2. Chitosan biopolymer, its derivatives and potential applications in nano-therapeutics: A comprehensive review
3. Evaluation of different β-cyclodextrins- and polymer-containing nasal powders
4. Effect of drying process on the physico-chemical properties of oxicam drugs
5. Interaction Studies Between Levodopa and Different Excipients to Develop Coground Binary Mixtures for Intranasal Application
6. Effect of solubility enhancement on nasal absorption of meloxicam
7. Nano-Spray-Dried Levocetirizine Dihydrochloride with Mucoadhesive Carriers and Cyclodextrins for Nasal Administration
8. The Effect of the Particle Size Reduction on the Biorelevant Solubility and Dissolution of Poorly Soluble Drugs with Different Acid-Base Character
9. Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles
10. Comparison of static and dynamic sonication as process intensification for particle size reduction using a factorial design
11. In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration
12. PREPARATION AND CHARACTERIZATION OF SMARTCRYSTALS FOR DISSOLUTION ENHANCEMENT OF POORLY WATER - SOLUBLE NIFLUMIC ACID.
13. Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam
14. Preparation and investigation of meloxicam potassium containing cyclodextrin nanoparticles intended for nasal application
15. Physico-Chemical, In Vitro and Ex Vivo Characterization of Meloxicam Potassium-Cyclodextrin Nanospheres
16. Comparison of Modern In Vitro Permeability Methods with the Aim of Investigation Nasal Dosage Forms
17. Physico-Chemical and In Vitro Characterization of Chitosan-Based Microspheres Intended for Nasal Administration
18. Formulation and In Vitro and In Silico Characterization of “Nano-in-Micro” Dry Powder Inhalers Containing Meloxicam
19. Development of spray-dried meloxicam-containing microcomposites using biocompatible matrix
20. Cyclodextrins in traditional and alternative drug formulations
21. Development of Intranasal Chitosan-Based Drug Delivery Containing Meloxicam <sup>†</sup>
22. Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity
23. Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach
24. Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems
25. Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells
26. The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam
27. The Effect of an OptimizedWet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam.
28. Application of wet milling techniques to produce micronized and nanonized drug pre-dispersions for the development of intranasal formulations
29. [Particle size reduction using acoustic cavitation].
30. [Optimization of technological parameters using acustic cavitation to reach particle size reduction of pharmacon].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.